The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Carcinoma, Ductal, Breast

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Carcinoma, Ductal, Breast


High impact information on Carcinoma, Ductal, Breast


Chemical compound and disease context of Carcinoma, Ductal, Breast


Gene context of Carcinoma, Ductal, Breast


  1. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias. Done, S.J., Arneson, N.C., Ozçelik, H., Redston, M., Andrulis, I.L. Cancer Res. (1998) [Pubmed]
  2. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Moinfar, F., Man, Y.G., Arnould, L., Bratthauer, G.L., Ratschek, M., Tavassoli, F.A. Cancer Res. (2000) [Pubmed]
  3. Breast cancer models to study the expression of estrogen receptors with small animal PET imaging. Aliaga, A., Rousseau, J.A., Ouellette, R., Cadorette, J., van Lier, J.E., Lecomte, R., Bénard, F. Nucl. Med. Biol. (2004) [Pubmed]
  4. Histochemistry of estrogen sulfatases in human breast diseases. Partanen, S. Virchows Arch., B, Cell Pathol. (1985) [Pubmed]
  5. p53 in Mammary ductal carcinoma in situ, mutations in high-grade lesions only? Simpson, J.F., Page, D.L., Edgerton, M.E. J. Natl. Cancer Inst. (2001) [Pubmed]
  6. Somatic mutations and altered expression of the candidate tumor suppressors CSNK1 epsilon, DLG1, and EDD/hHYD in mammary ductal carcinoma. Fuja, T.J., Lin, F., Osann, K.E., Bryant, P.J. Cancer Res. (2004) [Pubmed]
  7. Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine. Carr, A., Rodríguez, E., Arango, M.d.e.l. .C., Camacho, R., Osorio, M., Gabri, M., Carrillo, G., Valdés, Z., Bebelagua, Y., Pérez, R., Fernández, L.E. J. Clin. Oncol. (2003) [Pubmed]
  8. p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas. Vanzulli, S., Efeyan, A., Benavides, F., Helguero, L.A., Peters, G., Shen, J., Conti, C.J., Lanari, C., Molinolo, A. Carcinogenesis (2002) [Pubmed]
  9. p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Poller, D.N., Roberts, E.C., Bell, J.A., Elston, C.W., Blamey, R.W., Ellis, I.O. Hum. Pathol. (1993) [Pubmed]
  10. Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture. Small, W., Molteni, A., Kim, Y.T., Taylor, J.M., Chen, Z., Ward, W.F. Breast Cancer Res. Treat. (1997) [Pubmed]
  11. Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment. Helguero, L.A., Viegas, M., Asaithamby, A., Shyamala, G., Lanari, C., Molinolo, A.A. Breast Cancer Res. Treat. (2003) [Pubmed]
  12. PTEN deficiency: a role in mammary carcinogenesis. Petrocelli, T., Slingerland, J.M. Breast Cancer Res. (2001) [Pubmed]
  13. Expression of maspin is up-regulated during the progression of mammary ductal carcinoma. Umekita, Y., Yoshida, H. Histopathology (2003) [Pubmed]
  14. Prognostic value of immunocytochemical estimation of estrogen receptor (ER) and of pS2 estrogen-dependent protein in cells of mammary ductal carcinoma. Analysis of five-year course of the disease. Surowiak, P., Dziegiel, P., Zabel, M., Matkowski, R., Kornafel, J. Folia Histochem. Cytobiol. (2001) [Pubmed]
  15. Analysis of estrogen receptor (ER) and estrogen-dependent pS2 protein expression in cells of mammary ductal carcinoma. Surowiak, P., Dziegiel, P., Zabel, M., Matkowski, R., Kornafel, J. Folia Histochem. Cytobiol. (2001) [Pubmed]
  16. Correlation of immunohistochemical markers with patient prognosis in breast carcinoma: a quantitative study. Barry, J.D., Koch, T.J., Cohen, C., Brigati, D.J., Sharkey, F.E. Am. J. Clin. Pathol. (1984) [Pubmed]
WikiGenes - Universities